Fig. 2From: N-acetylcysteine in COPD: why, how, and when? a Mean time to first exacerbation; b mean cumulative exacerbation frequency in Chinese COPD patients treated with high-dose NAC or placebo in adjunct to usual therapy for one year and divided according to basal high or low exacerbation risk. Mod. from [111]Back to article page